Which patients are good candidates for TMS Therapy?
TMS Therapy is an appropriate treatment option for adult patients with Major Depressive Disorder who have failed to achieve satisfactory improvement from one prior antidepressant medication at or above the minimal effective dose and duration in the current episode.
In clinical trials, half of the patients had been treated with at least four medication treatment attempts, one of which was at an adequate dose and duration.
TMS Therapy has not been studied in patients who have not received prior antidepressant treatment. Efficacy has not been established in patients who have failed to receive benefit from two or more prior antidepressant medications at minimal effective dose and duration in the current episode. TMS has not been demonstrated to be a substitute for electroconvulsive therapy (ECT).
Not all patients are appropriate candidates for NeuroStar TMS Therapy. To determine if NeuroStar TMS Therapy may be right for you, talk with your physician.
Which patients should not receive TMS Therapy?
TMS Therapy should not be used in patients with implanted metallic devices or non-removable metallic objects in or around the head (for example, metal plates in the skull, aneurysm coils, etc.) because serious injury could result.
Patients with braces and metal fillings are acceptable for treatment; however, patients with other metal within their mouth should discuss this with their physician.
NeuroStar TMS Therapy should not be used in patients with implants controlled by physiological signals. This includes pacemakers, implantable cardioverter defibrillators (ICDs) and vagus nerve stimulators (VNS).
For more information, please call UNC Mental Health Specialists at 919-445-0770.